According to the IHC results, the areas positively stained for Neutrophil gelatinase‐associated lipocalin (NGAL), TRPC5, and 8‐OHdG (an oxidative DNA damage marker) in regions with glomerular sclerosis were decreased after GQDs administration compared with that observed in the AD‐injected group (Figure 3A). The gene discussed is TRPC5; the disease is Alzheimer disease.